NewsRamp Science, Exploration and Discovery Podcast
Quantum BioPharma Advances Lucid-MS to Phase 2; Trailbreaker Resources Completes Maiden Drill Program
Aug 10, 2026
1:59
-(0)
About this episode
Quantum BioPharma receives FDA clearance for Lucid-MS Phase 2 trial in multiple sclerosis treatment, while Trailbreaker Resources finishes maiden drill program at Atsutla Gold Project, awaiting assay results.
Comments
Rate this episode
Episode Details
- Author
- NewsRamp
- Show Type
- full
- Audio Format
- audio/mpeg